Rookus M - Search Results

1

Reproductive and hormonal factors, and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: results from the International BRCA1/2 Carrier Cohort Study.

Antoniou AC, Rookus M, Andrieu N, Brohet R, Chang-Claude J, Peock S, Cook M, Evans DG, Eeles R; EMBRACE; Nogues C, Faivre L, Gesta P; GENEPSO; van Leeuwen FE, Ausems MG, Osorio A; GEO-HEBON; Caldes T, Simard J, Lubinski J, Gerdes AM, Olah E, Fürhauser C, Olsson H, Arver B, Radice P, Easton DF, Goldgar DE. Antoniou AC, et al. Among authors: rookus m. Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):601-10. doi: 10.1158/1055-9965.EPI-08-0546. Epub 2009 Feb 3. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19190154 Free article.

2

Differences in breast cancer risk factors to neu (c-erbB-2) protein overexpression of the breast tumor.

Treurniet HF, Rookus MA, Peterse HL, Hart AA, van Leeuwen FE. Treurniet HF, et al. Among authors: rookus ma. Cancer Res. 1992 Apr 15;52(8):2344-5. Cancer Res. 1992. PMID: 1348449

3

[Does breast feeding protect against breast cancer? An epidemiological study].

Haring MH, Rookus MA, van Leeuwen FE. Haring MH, et al. Among authors: rookus ma. Ned Tijdschr Geneeskd. 1992 Apr 11;136(15):743-7. Ned Tijdschr Geneeskd. 1992. PMID: 1560867 Dutch.

4

Agreement between oral contraceptive users and prescribers: implications for case-control studies.

van Leeuwen FE, van Duijn CM, Camps MH, Kempers BA, Mentjens MF, Mulder HB, Schouten EG, Zwijsen RM, Rookus MA. van Leeuwen FE, et al. Among authors: rookus ma. Contraception. 1992 May;45(5):399-408. doi: 10.1016/0010-7824(92)90154-l. Contraception. 1992. PMID: 1623713 Free article.

5

The role of exogenous hormones in the epidemiology of breast, ovarian and endometrial cancer.

van Leeuwen FE, Rookus MA. van Leeuwen FE, et al. Among authors: rookus ma. Eur J Cancer Clin Oncol. 1989 Dec;25(12):1961-72. doi: 10.1016/0277-5379(89)90378-7. Eur J Cancer Clin Oncol. 1989. PMID: 2698811 Review.

6

Oral contraceptives and risk of breast cancer in women aged 20-54 years. Netherlands Oral Contraceptives and Breast Cancer Study Group.

Rookus MA, van Leeuwen FE. Rookus MA, et al. Lancet. 1994 Sep 24;344(8926):844-51. doi: 10.1016/s0140-6736(94)92826-6. Lancet. 1994. PMID: 7916400

7

p53 protein overexpression in relation to risk factors for breast cancer.

van der Kooy K, Rookus MA, Peterse HL, van Leeuwen FE. van der Kooy K, et al. Among authors: rookus ma. Am J Epidemiol. 1996 Nov 15;144(10):924-33. doi: 10.1093/oxfordjournals.aje.a008862. Am J Epidemiol. 1996. PMID: 8916503

8

Induced abortion and risk for breast cancer: reporting (recall) bias in a Dutch case-control study.

Rookus MA, van Leeuwen FE. Rookus MA, et al. J Natl Cancer Inst. 1996 Dec 4;88(23):1759-64. doi: 10.1093/jnci/88.23.1759. J Natl Cancer Inst. 1996. PMID: 8944006

9

[Last word on hormone replacement and breast cancer?].

Rookus MA, van Leeuwen FE, Hamerlynck JV. Rookus MA, et al. Ned Tijdschr Geneeskd. 1998 Jan 17;142(3):111-3. Ned Tijdschr Geneeskd. 1998. PMID: 9557006 Dutch.

10

Physical activity and breast cancer risk in women aged 20-54 years.

Verloop J, Rookus MA, van der Kooy K, van Leeuwen FE. Verloop J, et al. Among authors: rookus ma. J Natl Cancer Inst. 2000 Jan 19;92(2):128-35. doi: 10.1093/jnci/92.2.128. J Natl Cancer Inst. 2000. PMID: 10639514

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

155 results

Search Page

Filters